a man gardening

Resources

Resources

Read recent press, publications, and announcements about Cognito and our Alzheimer’s treatment.

Scroll Down
All Time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
11 Dec
2023
Cognito Therapeutics reports non-invasive neuromod data for treating Alzheimer’s
Press Releases
30 Oct
2023
Neuromod tech developer Cognito Therapeutics has a new CCO
Press Releases
30 Oct
2023
Cognito Therapeutics Appoints Christian Howell as Chief Commercial Officer
Press Releases
27 Oct
2023
Clinical Potential of Cognito’s Gamma Sensory Stimulation Device in Alzheimer Disease: Brent Vaughan
Press Releases
24 Oct
2023
Cognito Therapeutics Presents Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety, Adherence and Durability of Treatment Benefits Over 18 Months
News Articles
18 Oct
2023
Cognito Therapeutics to Present Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety and Durability of Treatment Benefits Over 18 Months at CTAD 2023
News Articles
No results found.
There are no results with this criteria. Try changing your search.